Urinary incontinence in US adults aged ≥55 years with type 2 diabetes and indications for SGLT2is: NHANES 2013–2020

Urinary incontinence in US adults aged ≥55 years with type 2 diabetes and indications for SGLT2is: NHANES 2013–2020

Objective Sodium-glucose cotransporter-2 inhibitors (SGLT2is) are recommended as first-line cardiorenal protective therapy in type 2 diabetes. Because SGLT2is cause glycosuria and increase urine volume, they may exacerbate incontinence symptoms among patients with pre-existing urinary incontinence....

Full description

Saved in:
Bibliographic Details
Main Authors: Sei J Lee, Eva Raphael, Kathryn E Callahan, Kasia J Lipska, Alexandra K Lee
Format: Article
Language:English
Published: BMJ Publishing Group 2025-07-01
Series:BMJ Open Diabetes Research & Care
Online Access:https://drc.bmj.com/content/13/4/e004929.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items